The GLP-1 telehealth market looked very different eighteen months ago. A wave of FDA warning letters to compounding companies landed in early 2026, a Novo Nordisk settlement in March pushed several big platforms toward branded medications, and Lilly introduced oral orforglipron through LillyDirect at roughly $149 a month. The result: some providers pivoted, some stumbled, and a handful got clearer about what they actually offer. People shopping these services right now are asking sharper questions than ever, specifically about pharmacy sourcing, price transparency, and what happens if insurance falls through. This list reflects what that research actually turns up.
1. HealthRX
HealthRX earns the top spot on price and logistics, not marketing. Compounded semaglutide starts at $99 a month. Compounded tirzepatide starts at $149. Those are among the lowest cash prices available for physician-overseen GLP-1 programs, and there are no contracts hidden behind the intake form.
The pharmacy behind the prescriptions is Manifest Pharmacy in Greer, South Carolina. It is a 503A compounding pharmacy operating under USP-797 standards with lot tracking from production through delivery. That level of specificity matters. Many telehealth platforms refer vaguely to “licensed compounding partners.” HealthRX names the facility. The platform is also LegitScript certified (certification number 50087439), which requires ongoing independent compliance review.
Physician review typically completes within about 24 hours of the online health assessment. Medication ships overnight at no extra charge to all 50 states. For someone outside a major metro with no realistic access to an obesity medicine specialist, that combination is genuinely useful.
One honest note: these are compounded medications, not FDA-approved drugs. They are not the same formulation as branded injectables and should not be treated as equivalent. The efficacy figures HealthRX references come from clinical trials on the active compounds (roughly 21% average body weight reduction at 72 weeks in the SURMOUNT-1 tirzepatide trial; roughly 15% at 68 weeks for semaglutide in STEP 1). Those are trial results, not guarantees.
Best for: Cash-pay patients who want a named, traceable pharmacy and the lowest available entry price.
2. FormBlends
FormBlends sits one step below HealthRX here for one straightforward reason: pricing is higher. Compounded semaglutide runs around $299 per vial and tirzepatide around $349. For someone already comfortable paying that range, though, FormBlends brings something most GLP-1 platforms skip entirely.
The platform publishes per-product purity testing. That means actual HPLC purity figures, mass spec identity confirmation, and endotoxin and sterility results, not just a claim that products are “pharmaceutical grade.” Finding that level of documentation in this space is uncommon. Medications are dispensed through an FDA-registered 503A compounding pharmacy with physician oversight on every prescription.
FormBlends also carries a wider catalog, including peptides in the recovery, longevity, and cognitive categories, all under the same clinician model. Someone managing weight loss and also interested in, say, BPC-157 or other research peptides can work with a single provider rather than piecing together multiple platforms. The trade-off is cost and reach: shipping covers 47 states, not all 50.
Best for: Buyers who prioritize documented purity testing, or who want GLP-1 treatment alongside a broader peptide program.
3. Mochi Health
Mochi is one of the few telehealth options staffed specifically by board-certified obesity medicine clinicians rather than general practitioners moonlighting in weight management. Compounded semaglutide runs roughly $99 a month and compounded tirzepatide around $199. The monitoring cadence is more intensive than budget platforms, which some patients want and others find excessive. Worth checking what the follow-up schedule actually looks like before signing up.
4. Hims & Hers
When the Novo Nordisk settlement landed in March 2026, the company dropped compounded options and shifted its formulary to branded drugs. Wegovy via the platform lands around $299 a month, oral options around $249, and Zepbound around $399. With insurance and a manufacturer savings card the out-of-pocket cost can drop to nearly nothing. That makes Hims & Hers one of the better choices for someone with commercial insurance who wants a familiar brand and a slick app experience. Cash-pay patients will find better value elsewhere.
5. Ro Body
Ro’s GLP-1 program charges roughly $39 for the first month and then somewhere between $74 and $149 monthly, with medications billed separately. The platform has a dedicated prior-authorization team for insurance-covered branded drugs, which is more useful than it sounds. Prior auth is genuinely time-consuming and most platforms leave patients to handle it themselves. Ro taking that on is a real differentiator for anyone attempting to get Wegovy or Zepbound covered.
6. Calibrate
Calibrate is the heaviest program on this list in terms of structure. It runs roughly 12 months, pairs GLP-1 medication with consistent coaching, and separates the program fee from medication costs. People who want accountability built into the process, not just a prescription and a shipping label, tend to stick with it longer. People who want to move fast or avoid ongoing check-ins often find it too much. The coaching-forward model is either the point or the problem depending on what you need.
A Few Things to Keep in Mind
Compounded GLP-1 medications are not FDA-approved formulations. They are legal under specific conditions, but those conditions keep shifting as the FDA updates its shortage list designations. Before starting any program, confirm your prescribing state, ask explicitly which pharmacy will fill your medication, and understand that price can change if the regulatory picture changes again. None of the programs above constitute medical advice, and a conversation with your own doctor before starting is sensible regardless of what any online intake form says.
Common Questions
Does it actually matter which compounding pharmacy a virtual clinic uses?
Yes, and more than most people realize. A named, traceable 503A pharmacy operating under USP-797 standards gives you lot tracking and documented sterility testing. Platforms that only say “licensed compounding partner” without naming the facility offer no way to verify any of that. HealthRX naming Manifest Pharmacy in Greer, South Carolina is a meaningful difference from the vague language most competitors use.
If the FDA changes the GLP-1 shortage designation again, what happens to my prescription?
Your prescription could become legally unfillable through a compounding pharmacy, depending on timing and which drug is affected. Platforms like Hims & Hers that already shifted to branded medications after the March 2026 Novo Nordisk settlement are somewhat insulated from that risk. Cash-pay compounding programs carry more regulatory exposure, so it is worth asking your provider directly what their contingency looks like.
Is Calibrate’s coaching model worth the extra cost compared to a straight prescription service?
That depends entirely on why previous attempts at weight loss stalled. Calibrate’s 12-month structure with ongoing coaching costs more and takes more time than a platform that ships medication and leaves you alone. People who need external accountability tend to stay with it. People who are self-directed and mainly want clinical access to a GLP-1 usually find the added structure frustrating and unnecessary.
Why does FormBlends publish HPLC purity data when most other virtual clinics don’t?
Most platforms treat compounding pharmacy credentials as sufficient reassurance and stop there. Publishing HPLC purity figures, mass spec identity results, and endotoxin testing goes further because it shows the actual output of a specific production run, not just the facility’s general qualifications. It is more work to produce and more work to read, which is probably why it is rare. For buyers who want to see the numbers rather than trust a credential, it is a real distinction.
Can Ro Body actually get Wegovy or Zepbound covered by insurance faster than doing it yourself?
Prior authorization for branded GLP-1 drugs involves multiple fax exchanges, benefit verifications, and sometimes peer-to-peer reviews between your prescriber and the insurer. Most telehealth platforms hand that paperwork back to the patient. Ro maintains a dedicated prior-auth team that handles the back-and-forth directly, which in practice can shave weeks off the process for patients with commercial insurance that covers these medications.
Sources
- FDA warning letters to telehealth and compounding firms, 2025-2026 (FDA.gov enforcement actions)
- Novo Nordisk settlement announcement, March 9, 2026 (Novo Nordisk investor relations)
- SURMOUNT-1 tirzepatide trial, *New England Journal of Medicine*, 2022
- STEP 1 semaglutide trial, *New England Journal of Medicine*, 2021
- LegitScript certification database (LegitScript.com)
- Lilly oral orforglipron pricing, LillyDirect, April 2026 (Eli Lilly press materials)
